Jos Kleinjans

2.8k citations

40 papers · 966 indexed · h-index 20

Molecular Biology
Pharmacology top 2%
Cancer Research top 10%
Health, Toxicology and Mutagenesis top 5%
Hepatology top 10%

Co-authors: Hans Verhagen P.A.E.L. Schilderman Joost H.M. van Delft Danyel Jennen Geja J. Hageman Theo M. de Kok Edwin C.M. Mariman Rob Stierum
Topics: Drug-Induced Hepatotoxicity and Protection (14 papers)Carcinogens and Genotoxicity Assessment (10 papers)Pharmacogenetics and Drug Metabolism (10 papers)
Cited by: Pharmacology Hepatology Cancer Research
Journals: Environmental Health Perspectives American Journal of Physiology-Heart and Circulatory Physiology Carcinogenesis
Partner nations: Netherlands United States Spain

In The Last Decade

Jos Kleinjans

39 papers receiving 932 citations

Peers

Countries citing papers authored by Jos Kleinjans

Since Specialization

Citations

This map shows the geographic impact of Jos Kleinjans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Kleinjans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Kleinjans more than expected).

Fields of papers citing papers by Jos Kleinjans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Kleinjans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Kleinjans. The network helps show where Jos Kleinjans may publish in the future.

Co-authorship network of co-authors of Jos Kleinjans

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Kleinjans. A scholar is included among the top collaborators of Jos Kleinjans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Kleinjans. Jos Kleinjans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes 2021 ·Archives of Toxicology ·Alfonso Quintás‐Cardama,(unknown),Isabel Conde,Eugenia Pareja,Jos Kleinjans,José V. Castell	30
2	Human 3D multicellular microtissues: An upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity 2019 ·Toxicology Letters ·Jian Jiang,Simon Messner,Jens Kelm,Marcel van Herwijnen,Danyel Jennen,Jos Kleinjans,Theo M. de Kok	17
3	The idiosyncratic drug-induced gene expression changes in HepG2 cells 2017 ·Data in Brief ·Jian Jiang,(unknown),(unknown),Sandra M.H. Claessen,(unknown),Jos Weusten,Ron Peters,Joost H. van Delft,Jos Kleinjans,Danyel Jennen,Theo M. de Kok	1
4	Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain 2015 ·Toxicology Letters ·Jian Jiang,Jacob J. Briedé,Danyel Jennen,(unknown),(unknown),Gert Schaart,Jos Kleinjans,Theo M. de Kok	63
5	Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices 2014 ·Toxicology ·Marlon J. Jetten,Sandra M.H. Claessen,Cornelis H.C. Dejong,Agustín Lahoz,José V. Castell,Joost H.M. van Delft,Jos Kleinjans	19
6	Performance in Omics Analyses of Blood Samples in Long-Term Storage: Opportunities for the Exploitation of Existing Biobanks in Environmental Health Research 2013 ·Environmental Health Perspectives ·Dennie G.A.J. Hebels,Panagiotis Georgiadis,Hector C. Keun,Toby J. Athersuch,Paolo Vineis,Roel Vermeulen,Lützen Portengen,Ingvar A. Bergdahl,Göran Hallmans,Domenico Palli,Benedetta Bendinelli,Vittorio Krogh,Rosario Tumino,Carlotta Sacerdote,Salvatore Panico,Jos Kleinjans,Theo M. de Kok,Martyn T. Smith,Soterios Α. Kyrtopoulos,(unknown)	112
7	Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models 2013 ·Carcinogenesis ·Tatyana Y. Doktorova,(unknown),Mathieu Vinken,Mireia Vilardell,Tamara Vanhaecke,Hans Gmuender,Roque Bort,Gabriella Brolén,Gustav Holmgren,Ruoya Li,Christophe Chesné,Joost van Delft,Jos Kleinjans,José V. Castell,Petter Björquist,Ralf Herwig,Vera Rogiers	42
8	'Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans 2012 ·Toxicology and Applied Pharmacology ·Marlon J. Jetten,Stan Gaj,Ainhoa Ruiz‐Aracama,Theo M. de Kok,Joost H.M. van Delft,Arjen Lommen,Eugene P. van Someren,Danyel Jennen,Sandra M.H. Claessen,Ad Peijnenburg,Rob Stierum,Jos Kleinjans	36
9	Complementary Detection of Embryotoxic Properties of Substances in the Neural and Cardiac Embryonic Stem Cell Tests 2012 ·Toxicological Sciences ·Peter T. Theunissen,Jeroen L. A. Pennings,Dorien A.M. van Dartel,Joshua F. Robinson,Jos Kleinjans,Aldert H. Piersma	29
10	Proteomics Investigations of Drug-Induced Hepatotoxicity in HepG2 Cells 2010 ·Toxicological Sciences ·(unknown),Johan Renes,Freek G. Bouwman,Jean‐Paul Noben,Joost H.M. van Delft,Jos Kleinjans,Edwin C.M. Mariman	84
11	Transcriptomic network analysis of micronuclei-related genes: a case study 2010 ·Mutagenesis ·Danitsja M. van Leeuwen,Marie Pedersen,Lisbeth E. Knudsen,Stefano Bonassi,Michael Fenech,Jos Kleinjans,Danyel Jennen	19
12	Parallelogram Approach Using Rat-Human In Vitro and Rat In Vivo Toxicogenomics Predicts Acetaminophen-induced Hepatotoxicity in Humans 2008 ·Toxicological Sciences ·Anne S. Kienhuis,Marcel C.G. van de Poll,Heleen M. Wortelboer,Marcel van Herwijnen,Ralph W.H. Gottschalk,Cornelis H.C. Dejong,André Boorsma,Richard S. Paules,Jos Kleinjans,Rob Stierum,Joost H.M. van Delft	33
13	Comparison of Coumarin-Induced Toxicity between Sandwich-Cultured Primary Rat Hepatocytes and Rats in Vivo: A Toxicogenomics Approach 2006 ·Drug Metabolism and Disposition ·Anne S. Kienhuis,Heleen M. Wortelboer,Jean-Christophe Hoflack,E.J.C. Moonen,Jos Kleinjans,Ben van Ommen,Joost H.M. van Delft,Rob Stierum	25
14	Interaction between cadmium and aromatic DNA adducts in hprt mutagenesis during foetal development 2005 ·Mutagenesis ·Roger Godschalk,Janneke Hogervorst,Harma J. Albering,(unknown),Frederik‐Jan van Schooten,Jelte de Haan,Jos Kleinjans	24
15	Nicotinic acid supplementation: Effects on niacin status, cytogenetic damage, and poly(ADP‐ribosylation) in lymphocytes of smokers 1998 ·Nutrition and Cancer ·Geja J. Hageman,Rob Stierum,Marcel H. M. van Herwijnen,(unknown),Jos Kleinjans	16
16	Effects of butylated hydroxyanisole on arachidonic acid and linoleic acid metabolism in relation to gastrointestinal cell proliferation in the rat 1992 ·Carcinogenesis ·P.A.E.L. Schilderman,Wim Engels,(unknown),B. Schütte,F. ten Hoor,Jos Kleinjans	6
17	Butylated hydroxyanisole in perspective 1991 ·Chemico-Biological Interactions ·Hans Verhagen,P.A.E.L. Schilderman,Jos Kleinjans	76
18	Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice 1991 ·Pharmacy World & Science ·(unknown),(unknown),Geja J. Hageman,(unknown),Jos Kleinjans	6
19	Disposition of single oral doses of butylated hydroxyanisole in man and rat 1989 ·Food and Chemical Toxicology ·Hans Verhagen,H.H.W. Thijssen,F. ten Hoor,Jos Kleinjans	30
20	Butylated hydroxyanisole, butylated hydroxytoluene and tert-butylhydroquinone are not mutagenic in the Salmonella/microsome assay using new tester strains 1988 ·Mutation Research Letters ·Geja J. Hageman,Hans Verhagen,Jos Kleinjans	30

About Jos Kleinjans

Jos Kleinjans is a scholar working on Pharmacology, Cancer Research and Hepatology, having authored 40 papers that have together received 966 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (14 papers), Carcinogens and Genotoxicity Assessment (10 papers) and Pharmacogenetics and Drug Metabolism (10 papers). The work is most often cited by research in Pharmacology (193 citations), Hepatology (109 citations) and Cancer Research (190 citations). Jos Kleinjans has collaborated with scholars based in Netherlands, United States and Spain. Frequent co-authors include Hans Verhagen, P.A.E.L. Schilderman, Joost H.M. van Delft, Danyel Jennen, Geja J. Hageman, Theo M. de Kok, Edwin C.M. Mariman, Rob Stierum, Johan Renes and Jean‐Paul Noben. Their work appears in journals such as Environmental Health Perspectives, American Journal of Physiology-Heart and Circulatory Physiology and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact